NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Narendra Modi
    Amit Shah
    Box Office Collection
    Bharatiya Janata Party (BJP)
    OTT releases
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / India News / India could approve coronavirus vaccine soon, key meeting today
    India could approve coronavirus vaccine soon, key meeting today
    India

    India could approve coronavirus vaccine soon, key meeting today

    Written by Shalini Ojha
    January 01, 2021 | 11:08 am 3 min read
    India could approve coronavirus vaccine soon, key meeting today

    After the meeting on Wednesday to judge the emergency use authorization applications of coronavirus vaccine developers remained without a conclusion, the subject expert committee (SEC) will meet again today. The panel will judge the pleas filed by Pune-based Serum Institute of India and Bharat Biotech. A proposal of US-based Pfizer could also be considered, the government said earlier, reports LiveMint. Here's more.

    After panel approves vaccine, DCGI will take up applications

    Once SEC gives the green signal to the vaccines, the applications will be sent to DCGI for the final nod. India, which has the second-highest number of coronavirus cases in the world, hopes to administer doses to at least 30 crore people in the coming six to eight months. The queue for vaccination will be led by healthcare workers and high-risk individuals.

    SII submitted more information after being directed to do so

    The country has placed its best bets on the vaccine developed by the University of Oxford and British-Swedish pharma giant AstraZeneca, whose millions of doses SII is producing. On December 9, the SEC of Central Drugs Standard Control Organisation (CDSCO) asked for more information from SII, which the company furnished on December 24. Bharat Biotech was also asked to give more data.

    SEC analyzed data submitted by SII and Bharat Biotech

    On Wednesday, the expert panel found some documents missing that had to be updated by SII, reports HT. "Further time was requested on behalf of Pfizer. The additional data and information presented by SII and Bharat Biotech Pvt. Ltd. were perused and analyzed by the SEC. The analysis of the additional data and information is going on," a statement revealed this week.

    Not long ago, Oxford's vaccine was approved by UK

    To note, the Oxford vaccine was approved by the United Kingdom on Wednesday, swelling its chances of getting the nod in India. Dr. Randeep Guleria of AIIMS had said, "This is very good news that AstraZeneca got approval for its vaccine by UK regulatory authorities. They have robust data and in India, the same vaccine is being developed by the Serum Institute of India."

    SII promised to prioritize home market before exporting doses

    Now, the Indian government is yet to sign an agreement with SII to purchase doses, but the company said it will give priority to the home market before exporting to other nations. SII, the largest vaccine maker in the world, has reportedly already produced 50 million doses of Covishield. CEO Adar Poonwalla asserted the vaccine will cost Rs. 700-800 for the private market.

    Dry run for vaccination will be held tomorrow

    The SEC meeting comes just a day before a dry run will be held in all states. In the first successful dry run last month, only four states, namely Andhra Pradesh, Assam, Gujarat, and Punjab, participated. "The activity is proposed to be conducted in all state capitals in at least three session sites; some states will also include districts...situated in difficult terrain/have poor logistical support," the Centre said.

    Vaccine is on horizon but follow precautions, urged PM Modi

    While there are enough indications to show that India will approve a vaccine soon, Prime Minister Narendra Modi on Thursday urged people to not lose sight of coronavirus-appropriate behavior. "Now the vaccine is on the horizon. It's a matter of time. But I still want to say: dawai bhi aur kadai bhi (get vaccinated, but take every precaution)," he underlined.

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Related News
    Pfizer
    Oxford
    Coronavirus
    Serum Institute of India
    Bharat Biotech

    Pfizer

    WHO approves Pfizer-BioNTech's coronavirus vaccine for emergency use World Health Organization
    How Delhi Airport plans to help in coronavirus vaccine distribution Indira Gandhi International Airport (Delhi)
    Can prepare vaccine against mutated virus in 6 weeks: BioNTech United Kingdom
    US President-elect Joe Biden receives coronavirus vaccine on live television Joe Biden

    Oxford

    Oxford-AstraZeneca release final-stage trial results, coronavirus vaccine labeled safe Oxford University
    Serum seeks emergency use approval for Oxford's coronavirus vaccine Pfizer
    SII to sue vaccine trial participant for Rs. 100 crore Indian Council of Medical Research (ICMR)
    Manufacturing error in Oxford-AstraZeneca coronavirus vaccine raises pertinent questions University of Oxford

    Coronavirus

    Aanand L. Rai tests positive for COVID-19 Bollywood
    Over 36K ventilators delivered to hospitals amid COVID-19: Health Ministry Ministry of Health and Family Welfare
    Poor air quality may affect recovered COVID-19 patients: Experts Pune
    Coronavirus: 'Davai bhi, kadaai bhi,' Modi calls for sustained caution Narendra Modi

    Serum Institute of India

    Centre extends COVID-19 surveillance guidelines till January 31 India
    Oxford/AstraZeneca vaccine should be effective against new variant: Report Oxford University
    Indian government could approve Oxford-AstraZeneca's coronavirus vaccine by next week India
    Coronavirus vaccination may start in January, says Health Minister NITI Aayog

    Bharat Biotech

    COVID-19 vaccine: India to produce 300 million Sputnik V doses India
    India's neighbors train experts for clinical trials of COVID-19 vaccine Sri Lanka
    How Delhi plans to carry out COVID-19 vaccinations All India Institute Of Medical Sciences (AIIMS)
    Here's how the government is planning to conduct COVID-19 vaccinations Times of India
    Next News Article

    Love India News?

    Subscribe to stay updated.

    India Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023